![]() |
|
|
Vol. 299, Issue 2, 575-582, November 2001
College of Pharmacy, University of Michigan, Ann Arbor, Michigan
(X.-Y.C., K.H., D.-M.O., C.-P.H., G.L.A.); and Department of
Pharmacology, University of Valencia, Burjassot, Spain (G.P.S.-C.)
The proton-coupled oligopeptide transporter (PEPT1) has been shown to
mediate mucosal cell transport of di- and tripeptide, and some
peptidomimetic drugs. In this study, we determined the correlation
between PEPT1 protein expression and the permeability of cephalexin, a
substrate of PEPT1, in human PEPT1 (hPEPT1)-overexpressed Caco-2 cells
(Caco-2/hPEPT1 cells) and rat jejunum. Caco-2/hPEPT1 cells with various
levels of hPEPT1 expression were established by an adenoviral
transfection system. The effective intestinal permeability
(Peff) in rat jejunum was evaluated using a single pass in
situ perfusion method. The level of PEPT1 in Caco-2/hPEPT1 cells and
rat intestinal mucosal samples was quantitated by densitometry after
immunoblotting and enhanced chemiluminescence detection. In
Caco-2/hPEPT1 cells, an excellent correlation was observed between
cephalexin uptake and hPEPT1 expression
(R2 = 0.96, P < 0.005). This demonstrates that cephalexin uptake is directly
proportional to hPEPT1 expression. In the rat perfusion study, the mean
Peff ± S.D. (n = 15) of
cephalexin was 3.89 ± 1.63 × 10
5 cm/s. A very
significant correlation between PEPT1 expression and cephalexin
permeability with an R2 = 0.63 (P < 0.001) was observed. This indicates that the
variation in PEPT1 expression is one of the major factors accounting
for variable intestinal cephalexin absorption. To our knowledge, this is the most direct evidence that variation of PEPT1 expression is
correlated with absorption permeability variation of peptide-like compounds in vitro and in vivo.
This article has been cited by other articles:
![]() |
T. Sugiura, Y. Kato, T. Wakayama, D. L. Silver, Y. Kubo, S. Iseki, and A. Tsuji PDZK1 Regulates Two Intestinal Solute Carriers (Slc15a1 and Slc22a5) in Mice Drug Metab. Dispos., June 1, 2008; 36(6): 1181 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Itagaki, Y. Saito, S. Kubo, Y. Otsuka, Y. Yamamoto, M. Kobayashi, T. Hirano, and K. Iseki H+-Dependent Transport Mechanism of Nateglinide in the Brush-Border Membrane of the Rat Intestine J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miret, L. Abrahamse, and E. M. de Groene Comparison of in Vitro Models for the Prediction of Compound Absorption across the Human Intestinal Mucosa J Biomol Screen, October 1, 2004; 9(7): 598 - 606. [Abstract] [PDF] |
||||
![]() |
B. L. Neudeck, J. M. Loeb, and N. G. Faith Lactobacillus casei Alters hPEPT1-Mediated Glycylsarcosine Uptake in Caco-2 Cells J. Nutr., May 1, 2004; 134(5): 1120 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Landowski, D. Sun, D. R. Foster, S. S. Menon, J. L. Barnett, L. S. Welage, C. Ramachandran, and G. L. Amidon Gene Expression in the Human Intestine and Correlation with Oral Valacyclovir Pharmacokinetic Parameters J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 778 - 786. [Abstract] [Full Text] [PDF] |
||||